BOLINGBROOK, Ill., May 1, 2024 /PRNewswire/ -- The Institute for Musculoskeletal Advancement (iMSKA) today appointed Tom Denninger, PT, DPT, OCS, FAAOMPT, as Executive Director. This is the first executive appointment by iMSKA, which announced its formation earlier this year. Mr. Denninger will play a pivotal role in shaping the strategy for equipping, training, and transforming MSK care delivery through research and post professional development.
"iMSKA represents a commitment to advance scientific MSK research while providing resources and opportunities for practicing professionals," Mr. Denninger said. "The opportunity for growth and innovation in the field has never been more exciting or crucial. I'm thrilled to lead the Institute and support its mission."
Mr. Denninger is joined by Ellen Shanley, PhD, PT, OCS, Senior Director of Practice Standards and Quality Improvement, and Adam Lutz, PT, DPT, PhD, MBA, Director of Care Quality and Innovation at iMSKA as board members and major contributors to the research and educational initiatives. ATI's Chief Information Officer Augustus Oakes will also serve on board, offering his insight and expertise on leveraging innovative technology in the healthcare space.
Founded by ATI Physical Therapy ("ATI" or the "Company") (NYSE: ATIP), a nationally recognized outpatient physical therapy provider in the United States, iMSKA's mission is to progress quality clinical care with a focus on value, including: post-operative and non-operative outcomes; early access to care; treatment fidelity; value-based care models; and the effect on outcome implementation science. Applications to become a Research Fellow or to attend an ABPTRFE-accredited Orthopedic Residency, Sports Residency, or Upper Extremity Fellowship program will be announced in the coming months.
Mr. Denninger also serves as Vice President of Clinical Development at ATI where he oversees ATI's post-professional education programs, research initiatives, and clinical development throughout the organization. Previously, Mr. Denninger was Senior Director of Learning and Development ATI Physical Therapy, where he oversaw all internal and external clinical education and development programs. Mr. Denninger has been with ATI since 2015 working in a variety of patient-facing, operational, and corporate roles. He completed his DPT and Orthopedic Residency at Sacred Heart University in Fairfield, CT and completed his fellowship in manual physical therapy through Evidence in Motion. Mr. Denninger has presented at national conferences and has multiple peer reviewed articles on the topic of manual therapy and medical screening.
iMSKA also announces an Advisory Board from partnering institutions who are thought leaders in the Musculoskeletal care space and bring insight, advice, and knowledge to strategically guide iMSKA in its research initiatives and support its overall mission as a nonprofit organization, including:
iMSKA has applied for registered 501(c)(3) status as a non-profit, research-based institution. For more information, please visit i-mska.org.
ABOUT iMSKA
The Institute for Musculoskeletal Advancement (iMSKA) was founded by ATI Physical Therapy to engage in scientific research to determine the causes of injuries, disorders, and diseases of the musculoskeletal system; to inform, improve, and advance the diagnosis, treatment, and rehabilitation of musculoskeletal injuries, disorders, and diseases; and to discover, develop, and promote best practices in clinical musculoskeletal care. For more information, please visit i-mska.org. iMSKA is based Bolingbrook, IL.
ABOUT ATI PHYSICAL THERAPY
At ATI Physical Therapy, we are committed to making every life an active life. We provide convenient access to high-quality care to prevent and treat musculoskeletal (MSK) pain. Our approximately 900 locations in 24 states and virtual practice operate under the largest single-branded platform built to support standardized clinical guidelines and operating processes. With outcomes from more than 3 million unique patient cases, ATI strives to utilize quality standards designed to deliver proven, predictable, and impactful patient outcomes. From preventative services in the workplace and athletic training support to outpatient clinical services and online physical therapy via our online platform, CONNECT™, a complete list of our service offerings can be found at ATIpt.com. ATI is based in Bolingbrook, Illinois.
Contact:
Genesa Garbarino
Garbo Communications
This email address is being protected from spambots. You need JavaScript enabled to view it.
424-499-7025
Rob Manker of ATI Physical Therapy
This email address is being protected from spambots. You need JavaScript enabled to view it.
630-430-4018
Last Trade: | US$5.00 |
Daily Change: | 0.0099 0.20 |
Daily Volume: | 9,179 |
Market Cap: | US$22.000M |
February 26, 2024 February 20, 2024 November 06, 2023 October 31, 2023 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORESurmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB